<DOC>
	<DOCNO>NCT00738595</DOCNO>
	<brief_summary>This study investigate efficacy EVT 302 , potent selective inhibitor Monoamine Oxidase - B , improve quit rate chronic cigarette smoker motivate quit smoking . EVT 302 compare placebo without open label nicotine replacement therapy .</brief_summary>
	<brief_title>Phase II Study Evaluate Effectiveness EVT 302 Smoking Cessation .</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Smoker least 10 cigarette daily Motivated quit smoke Reports least one unsuccessful attempt quit last 2 year In generally good health Provides write informed consent participate sudy Pregnant nursing female . Women childbearing potential must agree use acceptable contraceptive precaution ( contraceptive pill one barrier method ) study 2months thereafter History anaphylaxis History alcohol drug abuse History current significant medical psychiatric disorder History presence cataract abnormality identify slit lamp investigation Use MAO inhibitor , pethidine , SSRIs , tricyclic antidepressant , nasal oral decongestant cold medicine contain ephedrine , pseudoephedrine sympathomimetics . Any medicine contraindicate use MAO inhibitor . Have carrier hepatitis B c HIV 1 2 Use tobacco product cigarettes Use nicotine replacement therapy past month Received investigational drug past 30 day Previous participation study MAOB inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Smoking Cessation</keyword>
</DOC>